4 completed, 1 recruiting, 1 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow lumateperone: new trials by email Literature Review of lumateperone trials Research Report on lumateperone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder Lumateperone (ITI-007), Placebo Tablet or Capsule - Stuttering, Adult | Phase 2 | Recruiting | CSTrials Inc. | 24 | 2026-04-18 | 2026-07-29 |
| Caplyta in Borderline Personality Disorder Caplyta, Placebo - Borderline Personality Disorder | Phase 2 | Completed | University of Chicago | 60 | 2023-05-10 | 2026-07-29 |
| ITI-007 (Lumateperone Tosylate) for Schizophrenia ITI-007 - Schizophrenia | Phase 2 | Terminated | New York State Psychiatric Institute | 4 | 2019-03-01 | 2021-11-04 |
| Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia ITI-007 - Schizophrenia | Phase 2 | Completed | Intra-Cellular Therapies, Inc. | 14 | 2014-10-01 | 2017-03-10 |
| Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia ITI-007, Placebo - Alzheimer's Disease | Phase 1 / Phase 2 | Completed | Intra-Cellular Therapies, Inc. | 35 | 2014-02-01 | 2017-11-17 |
| Study of a Novel Antipsychotic ITI-007 in Schizophrenia ITI-007, Placebo, Risperidone - Schizophrenia | Phase 2 | Completed | Intra-Cellular Therapies, Inc. | 335 | 2011-12-01 | 2025-10-03 |
Schizophrenia (3) · Alzheimer Disease (1) · Borderline Personality Disorder (1) · Dementia (1) · Stuttering (1)
Intra-Cellular Therapies, Inc. (3) · CSTrials Inc. (1) · New York State Psychiatric Institute (1) · University of Chicago (1)
United States (6)
Dean F. Wong, M.D., Ph.D. (1) · Gerald A Maguire, MD (1) · Jeffrey A Lieberman, MD (1) · Jon E Grant, MD, JD, MPH (1) · Kimberly E Vanover, PhD (1) · Kimberly Vanover, Ph.D. (1)
PMID 26444072, PMID 28738099, PMID 31369655, PMID 33642973, PMID 36883881